Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | NA | NA |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.08 | 1.74 |
NAV | ₹20.20 | ₹82.00 |
Fund Started | 22 Jan 2015 | 17 Nov 2003 |
Fund Size | ₹156.73 Cr | ₹3406.09 Cr |
Exit Load | - | Exit load for units in excess of 15% of the investment, 1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.49% | 6.93% |
3 Year | 10.79% | 12.07% |
5 Year | 7.62% | 11.99% |
1 Year
3 Year
5 Year
Equity | 20.40% | 20.96% |
Cash | 2.98% | 3.94% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 2.77% |
HDFC Bank Ltd. | 2.30% |
Reliance Industries Ltd. | 1.63% |
State Bank of India | 1.55% |
Larsen & Toubro Ltd. | 1.11% |
NTPC Ltd. | 1.01% |
Infosys Ltd. | 1.00% |
Axis Bank Ltd. | 0.99% |
Mahindra & Mahindra Ltd. | 0.76% |
Dixon Technologies (India) Ltd. | 0.70% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 2.50% |
HDFC Bank Ltd. | 2.00% |
State Bank of India | 1.19% |
Axis Bank Ltd. | 1.14% |
Reliance Industries Ltd. | 1.04% |
Infosys Ltd. | 0.78% |
Larsen & Toubro Ltd. | 0.76% |
Bharti Airtel Ltd. | 0.76% |
ITC Ltd. | 0.74% |
Sun Pharmaceutical Industries Ltd. | 0.74% |
Name | Akshay Sharma | Dhruv Muchhal |
Start Date | 01 Dec 2022 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to provide capital appreciation and consistent income to the investors which will be in line with their retirement goals by investing in a mix of securities comprising of equity, equity related instruments and fixed income securities. | The scheme seeks to generate income/capital appreciation by investing primarily in debt securities, money market instruments and moderate exposure to equities. |
Launch Date | 22 Jan 2015 | 17 Nov 2003 |
Description
Launch Date